About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
International Journal of Cancer
›
Top Articles
International Journal of Cancer
Oncology
7.5
(top 1%)
Impact Factor
8.1
(top 1%)
extended IF
269
(top 1%)
H-Index
15.4K
authors
26.1K
papers
1.2M
citations
12.4K
citing journals
244.4K
citing authors
Most Cited Articles of International Journal of Cancer
Title
Year
Citations
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012
2015
19.3K
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
2010
12.1K
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
2019
3.3K
Estimating the world cancer burden: Globocan 2000
2001
2.8K
Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation
1983
2.2K
The global health burden of infection-associated cancers in the year 2002
2006
2.1K
Establishment and characterization of a human histiocytic lymphoma cell line (U-937)
1976
2.1K
Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices
1975
1.9K
Binding of soluble form of fibroblast surface protein, fibronectin, to collagen
1977
1.7K
Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)
1980
1.6K
Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines
1973
1.5K
The urokinase-type plasminogen activator system in cancer metastasis: a review
1997
1.4K
Estimates of the worldwide incidence of 25 major cancers in 1990
1999
1.3K
Estimates of the worldwide incidence of eighteen major cancers in 1985
1993
1.3K
Global estimates of cancer prevalence for 27 sites in the adult population in 2008
2013
1.3K
Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update
2007
1.2K
Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity
1975
1.1K
Estimates of the worldwide mortality from 25 cancers in 1990
1999
1K
A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells
1976
1K
Cancer risk in mutation carriers of DNA-mismatch-repair genes
1999
905
Isolation of a human prostate carcinoma cell line (DU 145)
1978
895
Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system
1984
887
Estimates of the worldwide frequency of sixteen major cancers in 1980
1988
879
Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
2011
845
Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri
2001
824
previous
2007
2008
2009
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.